tirzepatide semaglutide blend Compounded Program: Results, Timeline & Comparison Tirzepatide & Semaglutide for Weight

Some people report dramatic hunger reduction, while others experience more modest effects

Mounjaro (tirzepatide), which is a GIP/GLP-1 agonist, and Victoza (liraglutide), a GLP-1 agonist, are used to treat Type 2 diabetes, while Zepbound (tirzepatide) and Saxenda (liraglutide) are used for weight loss

The metabolic improvements associated with weight lossreduced insulin resistance, decreased inflammation, and improved lipid profilesall contribute to hormonal rebalancing that may temporarily disrupt established (albeit irregular) menstrual patterns before ultimately improving cycle regularity in many cases

Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice